MUMBAI, India, Jan. 9 -- Intellectual Property India has published a patent application (202541065895 A) filed by Dr. Kiran Kumar Nalla; Dr. Bangaru Naidu Thaddi; Dr. Narendra Kelam; Mr. Althaf Hussain Shaik; Dr. Mohammed Rahamtulla; and Prof. B. E. V. L. Naidu, Hyderabad, Telangana, on July 10, 2025, for 'quercetin-based nano-formulation for dual anticancer and antibacterial therapeutic applications.'
Inventor(s) include Dr. Kiran Kumar Nalla; and Dr. Bangaru Naidu Thaddi.
The application for the patent was published on Jan. 9, under issue no. 02/2026.
According to the abstract released by the Intellectual Property India: "The present disclosure proposes a quercetin-based nano-formulation designed for dual therapeutic applications namely, anticancer and antibacterial treatments. The quercetin-based nano-formulation comprises quercetin as an active compound, encapsulated or conjugated within a nanocarrier system selected from the group consists of liposomes, polymeric nanoparticles, micelles, and dendrimers. The quercetin-based nano-formulation is designed for dual therapeutic use against cancer and bacterial infections by enhancing bioavailability, cellular uptake, and selective cytotoxicity. The quercetin-based nano-formulation. enhances the bioavailability, stability, and cellular uptake of quercetin for therapeutic use. The quercetin-based nano-formulation evaluates the anticancer potential of the nano-formulated quercetin against various human cancer cell lines, with particular emphasis on breast and lung cancer models. The quercetin-based nano-formulation investigates the antibacterial efficacy of the nano-formulation against a broad spectrum of pathogens, including both Gram-positive and Gram-negative bacterial strains."
Disclaimer: Curated by HT Syndication.
